Boditech Med Inc. (KOSDAQ:206640)

Market Cap	302.46B
Revenue (ttm)	144.17B
Net Income (ttm)	27.86B
Shares Out	21.79M
EPS (ttm)	1,272.37
PE Ratio	10.91
Forward PE	9.32
Dividend	150.00 (1.08%)
Ex-Dividend Date	Mar 31, 2025

Volume	61,425
Average Volume	48,727
Open	13,770
Previous Close	13,790
Day's Range	13,660 - 14,130
52-Week Range	13,350 - 19,290
Beta	0.17
RSI	44.10
Earnings Date	Aug 11, 2025

About Boditech Med

Boditech Med Inc. offers instruments and diagnostic reagents in South Korea and internationally. The company offers instruments, including ichroma II, diagnostic immuno-analyzer to measure the presence of various biomarkers for cardiac, cancer, hormones, infectious diseases, autoimmune diseases, and metabolic diseases; ichroma III, a high-throughput immuno-analyzer that enables simultaneous testing for various parameters; ExAmplar, a compact real time PCR that detects virus/bacteria quantitatively or qualitatively using ready-to-use cartridges;...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1998
• Employees: 515
• Stock Exchange: KOSDAQ
• Ticker Symbol: 206640

Financial Performance

In 2024, Boditech Med's revenue was 138.16 billion, an increase of 2.94% compared to the previous year's 134.22 billion. Earnings were 27.26 billion, an increase of 5.06%.